|
gptkbp:instanceOf
|
vaccine
|
|
gptkbp:administeredBy
|
gptkb:wildlife
domestic animals
injection
people at high risk of exposure
people exposed to rabid animals
rabies immunoglobulin (in some cases)
|
|
gptkbp:approvedBy
|
gptkb:World_Health_Organization
gptkb:U.S._Food_and_Drug_Administration
|
|
gptkbp:ATCCode
|
gptkb:J07BG01
|
|
gptkbp:boosterRecommended
|
yes
|
|
gptkbp:broadcastOn
|
multiple doses
|
|
gptkbp:category
|
gptkb:WHO_essential_medicine
travel vaccine
veterinary vaccine
|
|
gptkbp:contains
|
inactivated rabies virus
|
|
gptkbp:contraindication
|
severe allergic reaction to previous dose
|
|
gptkbp:cost
|
varies by country
|
|
gptkbp:developedBy
|
gptkb:Louis_Pasteur
1885
|
|
gptkbp:duration
|
years
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Rabies vaccine
|
|
gptkbp:indication
|
animals
humans
|
|
gptkbp:legalStatus
|
prescription only
|
|
gptkbp:manufacturer
|
gptkb:Bharat_Biotech
gptkb:Sanofi
gptkb:Serum_Institute_of_India
GlaxoSmithKline
|
|
gptkbp:notRecommendedFor
|
pregnant women (unless at high risk)
|
|
gptkbp:prevention
|
rabies
|
|
gptkbp:routeOfAdministration
|
intramuscular
intradermal
|
|
gptkbp:sideEffect
|
fever
headache
allergic reaction
pain at injection site
|
|
gptkbp:storage
|
2-8°C
|
|
gptkbp:type
|
vaccine
nerve tissue vaccine
cell culture vaccine
|
|
gptkbp:usedFor
|
post-exposure prophylaxis
pre-exposure prophylaxis
|
|
gptkbp:usedIn
|
gptkb:veterinary_medicine
public health programs
travel medicine
|
|
gptkbp:WHO_Essential_Medicines_List
|
yes
|
|
gptkbp:bfsParent
|
gptkb:Serum_Institute_of_India
|
|
gptkbp:bfsLayer
|
6
|